Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Best Pract Res Clin Anaesthesiol ; 34(3): 463-477, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33004159

RESUMEN

Chronic pain can be recurrent or constant pain that lasts for longer than 3 months and can result in disability, suffering, and a physical disturbance. Related to the complex nature of chronic pain, treatments have a pharmacological and non-pharmacological approach. Due to the opioid epidemic, alternative therapies have been introduced, and components of the plant Cannabis Sativa, Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have gained recent interest as a choice of treatment. The exact mechanism for CBD is currently unknown, but unlike the CBD's psychoactive counterpart, THC, the side effects of CBD itself have been shown to be overall much more benign. The current pharmaceutical products for the treatment of chronic pain are known as nabiximols, and they contain a ratio of THC combined with CBD, which has been promising. This review focuses on the treatment efficacy of CBD, THC: CBD-based treatments for chronic pain and adverse events with each.


Asunto(s)
Analgésicos/administración & dosificación , Cannabidiol/administración & dosificación , Agonistas de Receptores de Cannabinoides/administración & dosificación , Dolor Crónico/tratamiento farmacológico , Dronabinol/administración & dosificación , Dolor Crónico/diagnóstico , Dolor Crónico/fisiopatología , Estudios Cruzados , Vías de Administración de Medicamentos , Combinación de Medicamentos , Quimioterapia Combinada , Humanos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA